ALR Technologies (ALRT) Stock Price, News & Analysis

Company Overview

ALR Technologies Inc., a data management company, develops diabetes care solutions for human and animal health in the United States. It provides Diabetes Management System, a comprehensive approach to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring, and diabetes test supplies. The company also offers Continuous Glucose Monitoring (CGM), a medical device that is worn on the body of a diabetic subject for blood sugar readings; and GluCurve Pet CGM to address an unmet need in diabetes care for felines and canines used by veterinarians in animal health, as well as Prediabetes System, which provides patients with educational videos and supplemental content formatted for mobile devices and a private online community to discuss disease management. Its primary business markets are health care providers, the providers of health insurance, and the providers of disease and case management services, including the home care industry. The company was formerly known as Mo Betta Corp. and changed its name to ALR Technologies Inc. in December 1998. ALR Technologies Inc. was incorporated in 1987 and is based in Richmond, Virginia.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.03 to $0.03
• 52-Week Range: $0.03 to $0.07
• Volume: 95,700 shs
• Average Volume: 71,792 shs
• Market Capitalization: $16.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Communications equipment, not elsewhere classified
• Sub-Industry: Electronic Equipment
• Current Symbol: OTCMKTS:ALRT
• CIK: 1087022
• Web: www.alrt.com
• Phone: (804) 554-3500
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$8.44 million
• Net Margins: N/A
• Pretax Margin: -95,715.64%
• Return on Equity: N/A
• Return on Assets: -4,825.80%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $10 thousand
• Price / Sales: 1,655.90
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: -0.75

Miscellaneous

• Outstanding Shares: 551,967,000
• Free Float: 157,311,000
• Market Cap: $16.56 million
• Optionable: Not Optionable
• Beta: 0.38